Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 Sep;23(9):2442-2449.
doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

I Ray-Coquard  1 , M C Montesco  2 , J M Coindre  3 , A P Dei Tos  4 , A Lurkin  5 , D Ranchère-Vince  6 , A Vecchiato  2 , A V Decouvelaere  6 , S Mathoulin-Pélissier  7 , S Albert  8 , P Cousin  6 , D Cellier  9 , L Toffolatti  4 , C R Rossi  10 , J Y Blay  11
Affiliations
Multicenter Study

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

I Ray-Coquard et al. Ann Oncol. 2012 Sep.

Abstract

Background: Sarcomas represent a heterogeneous group of tumors. Accurate determination of histological diagnosis and prognostic factors is critical for the delineation of treatment strategies. The contribution of second opinion (SO) to improve diagnostic accuracy has been suggested for sarcoma but has never been established in population-based studies.

Methods: Histological data of patients diagnosed with sarcoma in Rhone-Alpes (France), Veneto (Italy) and Aquitaine (France) over a 2-year period were collected. Initial diagnoses were systematically compared with SO from regional and national experts.

Results: Of 2016 selected patients, 1463 (73%) matched the inclusion criteria and were analyzed. Full concordance between primary diagnosis and SO (the first pathologist and the expert reached identical conclusions) was observed in 824 (56%) cases, partial concordance (identical diagnosis of connective tumor but different grade or histological subtype) in 518 (35%) cases and complete discordance (benign versus malignant, different histological type or invalidation of the diagnosis of sarcoma) in 121 (8%) cases. The major discrepancies were related to histological grade (n = 274, 43%), histological type (n = 144, 24%), subtype (n = 18, 3%) and grade plus subtype or grade plus histological type (n = 178, 29%).

Conclusion: More than 40% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions.

PubMed Disclaimer

References

    1. Colonna M, Hedelin G, Esteve J, et al. National cancer prevalence estimation in France. Int J Cancer. 2000;87(2):301–304. - PubMed
    1. Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhone-Alpes region] Bull Cancer. 2010;97(6):629–641. - PubMed
    1. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006;48(1):3–12. - PubMed
    1. Ray-Coquard I, Thiesse P, Ranchere-Vince D, et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004;15:307–315. - PubMed
    1. Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679–1689. - PubMed

Publication types